Implementing decision aids for cardiovascular disease prevention: stakeholder interviews and case studies in Australian primary care
-
Published:2024-02-03
Issue:1
Volume:25
Page:
-
ISSN:2731-4553
-
Container-title:BMC Primary Care
-
language:en
-
Short-container-title:BMC Prim. Care
Author:
Bonner Carissa,Cornell Samuel,Pickles Kristen,Batcup Carys,de Wet Carl,Morgan Mark,Greaves Kim,O’Connor Denise,Hawkes Anna L,Crosland Paul,Chapman Niamh,Doust Jenny
Abstract
Abstract
Background
Australian cardiovascular disease (CVD) prevention guidelines recommend absolute CVD risk assessment, but less than half of eligible patients have the required risk factors recorded due to fragmented implementation over the last decade. Co-designed decision aids for general practitioners (GPs) and consumers have been developed that improve knowledge barriers to guideline-recommended CVD risk assessment and management. This study used a stakeholder consultation process to identify and pilot test the feasibility of implementation strategies for these decision aids in Australian primary care.
Methods
This mixed methods study included: (1) stakeholder consultation to map existing implementation strategies (2018-20); (2) interviews with 29 Primary Health Network (PHN) staff from all Australian states and territories to identify new implementation opportunities (2021); (3) pilot testing the feasibility of low, medium, and high resource implementation strategies (2019-21). Framework Analysis was used for qualitative data and Google analytics provided decision support usage data over time.
Results
Informal stakeholder discussions indicated a need to partner with existing programs delivered by the Heart Foundation and PHNs. PHN interviews identified the importance of linking decision aids with GP education resources, quality improvement activities, and consumer-focused prevention programs. Participants highlighted the importance of integration with general practice processes, such as business models, workflows, medical records and clinical audit software. Specific implementation strategies were identified as feasible to pilot during COVID-19: (1) low resource: adding website links to local health area guidelines for clinicians and a Heart Foundation toolkit for primary care providers; (2) medium resource: presenting at GP education conferences and integrating the resources into audit and feedback reports; (3) high resource: auto-populate the risk assessment and decision aids from patient records via clinical audit software.
Conclusions
This research identified a wide range of feasible strategies to implement decision aids for CVD risk assessment and management. The findings will inform the translation of new CVD guidelines in primary care. Future research will use economic evaluation to explore the added value of higher versus lower resource implementation strategies.
Funder
the National Health and Medical Research Council
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Doust J, Sanders S, Shaw J, Glasziou P. Prioritising CVD prevention therapy - absolute risk versus individual risk factors. Aust Fam Physician. 2012;41(10):805–9.
2. National Institute for Health and Care Excellence. Cardiovascular disease: risk assessment and reduction, including lipid modification [CG181]. 2023. https://www.nice.org.uk/guidance/cg181. Accessed 16 Sep 2023.
3. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA Guideline on the primary Prevention of Cardiovascular Disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice guidelines. Circ. 2019;140(11):e596–e646.
4. Montori VM, Brito JP, Ting HH. Patient-centered and practical application of new high cholesterol guidelines to prevent Cardiovascular Disease. JAMA. 2014;311(5):465–6.
5. Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of Cardiovascular Disease: prospective cohort study. BMJ. 2017;357:j2099.